Jundishapur Journal of Microbiology

Published by: Kowsar

Post Neurosurgical Meningitis due to Colistin Heteroresistant Acinetobacter baumannii

Mojtaba Moosavian 1 , Saeed Shoja 1 , 2 , * , Roohangiz Nashibi 3 , Nasim Ebrahimi 1 , Mohammad Amin Tabatabaiefar 4 , Soodabeh Rostami 1 and Amir Peymani 5
Authors Information
1 Microbiology Department, Infectious and Tropical Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
2 Infectious and Tropical Diseases Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, IR Iran
3 Infectious and Tropical Diseases Research Center, Razi Hospital, Infectious and Tropical Disease Ward, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
4 Genetic Department, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
5 Microbiology Department, Qazvin University of Medical Sciences, Qazvin, IR Iran
Article information
  • Jundishapur Journal of Microbiology: October 01, 2013, 7 (10); e12287
  • Published Online: October 1, 2013
  • Article Type: Case Report
  • Received: May 18, 2013
  • Revised: September 22, 2013
  • Accepted: October 20, 2013
  • DOI: 10.5812/jjm.12287

To Cite: Moosavian M, Shoja S, Nashibi R, Ebrahimi N, Tabatabaiefar M A, et al. Post Neurosurgical Meningitis due to Colistin Heteroresistant Acinetobacter baumannii, Jundishapur J Microbiol. 2013 ; 7(10):e12287. doi: 10.5812/jjm.12287.

Copyright © 2013, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Case Presentation
3. Discussion
  • 1. Kempf M, Rolain JM. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options. Int J Antimicrob Agents. 2012; 39(2): 105-14[DOI][PubMed]
  • 2. Cascio A, Conti A, Sinardi L, Iaria C, Angileri FF, Stassi G, et al. Post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis successfully treated with intrathecal colistin. A new case and a systematic review of the literature. Int J Infect Dis. 2010; 14(7)-9[DOI][PubMed]
  • 3. Kim BN, Peleg AY, Lodise TP, Lipman J, Li J, Nation R, et al. Management of meningitis due to antibiotic-resistant Acinetobacter species. Lancet Infect Dis. 2009; 9(4): 245-55[DOI][PubMed]
  • 4. Khan FY, Abukhattab M, Baager K. Nosocomial postneurosurgical Acinetobacter baumannii meningitis: a retrospective study of six cases admitted to Hamad General Hospital, Qatar. J Hosp Infect. 2012; 80(2): 176-9[DOI][PubMed]
  • 5. Tuon FF, Penteado-Filho SR, Amarante D, Andrade MA, Borba LA. Mortality rate in patients with nosocomial Acinetobacter meningitis from a Brazilian hospital. Braz J Infect Dis. 2010; 14(5): 437-40[PubMed]
  • 6. Paramythiotou E, Karakitsos D, Aggelopoulou H, Sioutos P, Samonis G, Karabinis A. Post-surgical meningitis due to multiresistant Acinetobacter baumannii. Effective treatment with intravenous and/or intraventricular colistin and therapeutic dilemmas. Med Mal Infect. 2007; 37(2): 124-5[DOI][PubMed]
  • 7. Metan G, Alp E, Aygen B, Sumerkan B. Acinetobacter baumannii meningitis in post-neurosurgical patients: clinical outcome and impact of carbapenem resistance. J Antimicrob Chemother. 2007; 60(1): 197-9[DOI][PubMed]
  • 8. Li J, Rayner CR, Nation RL, Owen RJ, Spelman D, Tan KE, et al. Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother. 2006; 50(9): 2946-50[DOI][PubMed]
  • 9. Cai Y, Chai D, Wang R, Liang B, Bai N. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies. J Antimicrob Chemother. 2012; 67(7): 1607-15[DOI][PubMed]
  • 10. Winn WC, Allen SD, Janda WM, Koneman EW, Schreckenberger PC, Procop GW, et al. Koneman's Color Atlas and Textbook of Diagnostic microbiology. 2006;
  • 11. Bou G, Cervero G, Dominguez MA, Quereda C, Martinez-Beltran J. PCR-based DNA fingerprinting (REP-PCR, AP-PCR) and pulsed-field gel electrophoresis characterization of a nosocomial outbreak caused by imipenem- and meropenem-resistant Acinetobacter baumannii. Clin Microbiol Infect. 2000; 6(12): 635-43[PubMed]
  • 12. Turton JF, Woodford N, Glover J, Yarde S, Kaufmann ME, Pitt TL. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol. 2006; 44(8): 2974-6[DOI][PubMed]
  • 13. Gundi VA, Dijkshoorn L, Burignat S, Raoult D, La Scola B. Validation of partial rpoB gene sequence analysis for the identification of clinically important and emerging Acinetobacter species. Microbiology. 2009; 155: 2333-41[DOI][PubMed]
  • 14. Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents. 2006; 27(4): 351-3[DOI][PubMed]
  • 15. M 100-S20 Performance standards for antimicrobial susceptibility testing: 20th informational supplement. 2011;
  • 16. TYGACIL (tigecycline) injection, powder, lyophilized, for solution. 2005;
  • 17. Zong Z, Lu X, Valenzuela JK, Partridge SR, Iredell J. An outbreak of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemase in western China. Int J Antimicrob Agents. 2008; 31(1): 50-4[DOI][PubMed]
  • 18. Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011; 70(1): 119-23[DOI][PubMed]
  • 19. Krol V, Hamid NS, Cunha BA. Neurosurgically related nosocomial Acinetobacter baumannii meningitis: report of two cases and literature review. J Hosp Infect. 2009; 71(2): 176-80[DOI][PubMed]
  • 20. Rodriguez CH, Barberis C, Nastro M, Bombicino K, Granados G, Vay C, et al. Impact of heteroresistance to colistin in meningitis caused by Acinetobacter baumannii. J Infect. 2012; 64(1): 119-21[DOI][PubMed]
  • 21. Rodriguez CH, Bombicino K, Granados G, Nastro M, Vay C, Famiglietti A. Selection of colistin-resistant Acinetobacter baumannii isolates in postneurosurgical meningitis in an intensive care unit with high presence of heteroresistance to colistin. Diagn Microbiol Infect Dis. 2009; 65(2): 188-91[DOI][PubMed]
  • 22. Motaouakkil S, Charra B, Hachimi A, Nejmi H, Benslama A, Elmdaghri N, et al. Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii. J Infect. 2006; 53(4): 274-8[DOI][PubMed]
  • 23. Saleem AF, Shah MS, Shaikh AS, Mir F, Zaidi AK. Acinetobacter species meningitis in children: a case series from Karachi, Pakistan. J Infect Dev Ctries. 2011; 5(11): 809-14[PubMed]
  • 24. Tutuncu EE, Kuscu F, Gurbuz Y, Ozturk B, Haykir A, Sencan I. Tigecycline use in two cases with multidrug-resistant Acinetobacter baumannii meningitis. Int J Infect Dis. 2010; 14 Suppl 3-6[DOI][PubMed]
  • 25. D'Arezzo S, Principe L, Capone A, Petrosillo N, Petrucca A, Visca P. Changing carbapenemase gene pattern in an epidemic multidrug-resistant Acinetobacter baumannii lineage causing multiple outbreaks in central Italy. J Antimicrob Chemother. 2011; 66(1): 54-61[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments